ArticleScientific reports2025
In transfusion-dependent thalassemia, neuronal damage biomarkers are associated with affective and chronic fatigue symptoms.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Affective and chronic fatigue symptoms are associated with serum neuronal damage markers in Parkinson's disease.Scientific reports · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Patients with transfusion-dependent thalassemia (TDT) are vulnerable to neurotoxicity due to frequent blood transfusions and the subsequent iron overload (IO) and inflammation. This vulnerability may contribute to the development of depression, anxiety, and chronic fatigue syndrome (CFS). This case-control study aims to investigate central nervous system injury biomarkers, including neuron-specific enolase (NSE), glial fibrillary acidic protein (GFAP), neurofilament light (NFL) and nestin, neuro-immune markers, such as C-reactive protein (CRP), interleukin (IL)-6, and IL-10, calcium, magnesium, copper, zinc, hematocrit, hemoglobin, iron and ferritin in 126 children with TDT and 41 healthy children. We examined the associations between these biomarkers and the Fibro-Fatigue (FF) Rating Scale, the Children's Depression Inventory (CDI), and the Spence Children's Anxiety Scale (SCAS) scores. Children with TDT showed significantly elevated FF, CDI, and SCAS scores, IO (as assessed using iron and ferritin levels), and higher NSE, GFAP, NFL, CRP, IL-6 and IL-10, and lower magnesium, zinc, and calcium as compared with healthy children. There were significant correlations between the CDI score and NFL, NSE and GFAP, SCAS score and NFL, and FF score and NFL and GFAP. The neuronal damage biomarkers were significantly associated with biomarkers of IO (including iron and ferritin) and the erythron (including lowered hematocrit and hemoglobin). These results suggest that IO-associated neurotoxicity and inflammation in children with TDT may contribute to symptoms of depression, anxiety, and chronic fatigue and may serve as potential therapeutic targets.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.